supported by a Grant(221S945)from the Scientific and Technological Research Council of Turkey(TUBITAK);an Aydin Adnan Menderes University Research Grant(ADU-TPF-20041).
Background:Raloxifene,a selective estrogen receptor modulator,is also known to be a lysosomotropic agent.The bioavailability of raloxifene is around 2%due to extensive hepatic transport.Exosomes are nanosized vesicles...
Objective: To investigate whether sequential regimen such as traditional anti-reabsorption medications followed by zoledronic acid could reduce the side effects after initiation of zoledronic acid in postmenopausal os...
supported by FIS/IMSS project No.FIS/IMSS/PROT/G13/1216;CGA received Beca de Excelencia en Investigación by Fundación IMSS,ACS;JJSU received financial support from CIS/IMSS;CONACy T,RPA received financial support from USC-CONACYT Postdoctoral Scholars Program
Estrogen receptor modulators are compounds of interest because of their estrogenic agonistic/antagonistic effects and tissue specificity. These compounds have many clinical applications, particularly for breast cancer...
The benefits of estrogen in cardiovascular system include a reduction in low-density lipoprotein cholesterol (LDL-C), decrease in LDL oxidation, and enhancement of vascular function [1]. Estrogen replacement therapy...
the Ministry of Education and Science ofthe Republic of Serbia for supporting these investigations through the Project 172052
Method validation presents a detailed investigation of analytical method and provision of the evidence that the method, when correctly applied, produces results that fit to the purpose. In order to achieve the method ...
supported by the "Six Talents Peak" of Jiangsu Province,China 973 Program(No.2007CB944005);Science and Technology Development Foundation of Nanjing Medical University(No.2011NJMU152)
Objective To investigate the neuroprotective effects and the mechanism of this protection of raloxifene (RLX), a selective estrogen receptor modulator.Methods MTT assay and flow cytometry with annexin V-FITC/PI stai...
Acknowledgements This work was supported by Grant from the Natural Science Foundation of Shandong Province, Ji-nan, Shandong, China (#Y2005C50), Grant-in-Aid for China-Japan Sasagawa Researchers, from the Ministry of Health, Beijing, China (#083). The authors are grateful to Chun-xi LIU and Zhi YANG for their excellent technical contributions.
Aim: To assess a novel hormone replacement therapy (HRT) paradigm using raloxifene, aspirin combined with estrogen in rabbit model of menopause. Methods: Female New Zealand white rabbits were ovariectomized or sha...
Selective estrogen receptor modulators (SERMs) are structurally different com- pounds that interact with intracellular estrogen receptors in target organs as estrogen receptor agonists and antagonists. Raloxifene is...
Acknowledgment This research was funded by the following grants: the National Basic Research Programs, China (973 Programs, No. 2009CB918904, No. 2010CB945003), the National Natural Science Foundation of China (No. 30872592), Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao, China (No. 30928027), and the key research project of Tianjin Municipal Science and Technology Commission, China (No. 09ZCKFSF00800).
Estrogen has important roles in the initiation and development of benign prostatic hyperplasia (BPH). Regulators of the estrogen receptor (ER) are tissue- and cell-specific. We evaluated the effect of estrogen ant...
Aim: To evaluate the protective effect of oral raloxifene on acute lung injury. Methods: Thirty adult, male Sprague-Dawley rats each weighing 180-210 g were used and divided into 3 groups: the raloxifene-lipopolysa...